As well, Group B patients exhibited an approximately two-fold increased risk of progression and death compared to those in Group A, with marginal significance (HR, 1.954 and 1.962, respectively).
← all excerpts
Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients.
1
—
—